Ichiro Hanamura
Aichi Medical University
Publications 76
#1Hiroyuki Takamatsu (Kanazawa University)H-Index: 18
#2Shohei Mizuno (Aichi Medical University)H-Index: 8
Last.Kazutaka SunamiH-Index: 17
view all 14 authors...
#1Aki Yanagi (Fukushima Medical University)H-Index: 1
#2Naohiro Tsuyama (Fukushima Medical University)H-Index: 16
Last.Akira Sakai (Fukushima Medical University)H-Index: 25
view all 17 authors...
#1Tatsuo Oyake (Iwate Medical University)H-Index: 6
#2Norifumi Sugawara (Iwate Medical University)H-Index: 1
Last.Shigeki Ito (Iwate Medical University)H-Index: 10
view all 18 authors...
#1Shohei Mizuno (Aichi Medical University)H-Index: 8
#2Koji Kawamura (Jichi Medical University)H-Index: 9
Last.Akiyoshi Takami (Aichi Medical University)H-Index: 26
view all 18 authors...
Clinical trials evaluating the role of autologous hematopoietic stem cell transplantation (auto-HCT) in multiple myeloma have mostly included patients aged <65 years. Therefore, this study was aimed to evaluate the efficacy and safety of auto-HCT in elderly patients with multiple myeloma in the era of novel agents. We retrospectively analyzed 2056 patients with multiple myeloma, who underwent auto-HCT in 2007–2014 (287 were aged ≥65 years). We evaluated the 100-day treatment-related mortality (T...
1 CitationsSource
#1Yuya NakagamiH-Index: 1
#2Susumu SuzukiH-Index: 13
Last.Akiyoshi TakamiH-Index: 26
view all 11 authors...
Gnetin-C is a naturally occurring stilbene derived from the seeds of Gnetum gnemon L., an edible plant native to Southeast Asia that is called melinjo. Although the biological properties and safety of G. gnemon extract, which contains nearly 3% Gnetin-C, have been confirmed in various human studies, whether or not pure Gnetin-C is safe for humans is unclear at present. We conducted a randomized, double-blind, placebo-controlled trial. Healthy subjects were randomly divided into two groups. The i...
1 CitationsSource
#1Michinori OguraH-Index: 39
#2Kazuhito YamamotoH-Index: 28
Last.Hirokazu NagaiH-Index: 16
view all 33 authors...
#1Kaori UchinoH-Index: 2
#2Shohei MizunoH-Index: 8
Last.Akiyoshi TakamiH-Index: 26
view all 20 authors...
#1Tatsuo Oyake (Iwate Medical University)H-Index: 6
#2Yuka Takemasa-Fujisawa (Iwate Medical University)H-Index: 1
Last.Yoji Ishida (Iwate Medical University)H-Index: 13
view all 11 authors...
Febrile neutropenia is often observed in patients with hematologic malignancies, especially in those with acute leukemia. Meropenem has potent and broad antibacterial activity against gram-positive and gram-negative bacteria, and is recommended as first-line empiric therapy for febrile neutropenia. In contrast, the safety and efficacy of doripenem in patients with febrile neutropenia and hematologic malignancies is limited. In this randomized, prospective, cooperative, open-label trial, we compa...
1 CitationsSource
#1Akira SatouH-Index: 7
#2Shogo BannoH-Index: 14
Last.Toyonori TsuzukiH-Index: 28
view all 12 authors...
2 CitationsSource